Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Research study

    Integrating NTD programme monitoring into routine health systems data: evaluating a DHIS2 platform for real-time mass administration of medicines reporting

    On this page

    • Main objectives
    • Summary
    • Reports
    On this page
    • Main objectives
    • Summary
    • Reports

    Main objectives

    • To assess how a DHIS2-based real-time reporting tool for mass drug administration (MDA) strengthens quality, accessibility and use of data for programmatic action at all levels
    • To assess whether the tool enhances government ownership of the data and the MDA programme in general
    • To assess whether the tool provides a reliable estimate of treatment coverage
    • To understand how the tool can be scaled up regardless of funder and location
    • To understand what improvements or adaptations are required to the tool or processes around use of the tool

    Summary

    An electronic MDA reporting platform was developed and rolled out in Nigeria in collaboration with the Nigeria Federal Ministry of Health (FMoH) using the District Health Information Software 2 (DHIS2). With the aim of setting up the platform for future use in more states, roll out and scaling up of the DHIS2 tool and rigorous evaluation were required to ensure maximum scalability, utility, integration with the health system and access and use of data.

    The pilot study was carried out in three LGAs (Babura, Sule Tankarkar and Taura) in Jigawa State during MDA using qualitative and quantitative approaches. The DHIS2 tool was then revised and optimised based on findings before scaling up in Enugu, Jigawa and Kwara states. MDA activities and data entries on the DHIS2 were monitored with toll free lines, after which treatment coverage and process evaluation was conducted. This included quantitative analysis of programme data and DHIS2 metadata, and qualitative analysis of focus group discussions, key informant interviews, joint analysis of ownership data and review meetings with relevant stakeholders.

    Key findings
    • Using DHIS2 for MDA increases data access and use, and would likely increase data quality over time. Ability to address errors and improve decision-making during campaigns are significant benefits
    • The reporting platform improved all three components of government ownership (data access, data control, data use) at all levels of the health system, though somewhat less so at the LGA level where the burden of data entry is high
    • Successful scale-up will require action on the key recommendations included in the study report
    Policy and practice implications

    Following this study, the Nigeria FMoH has developed national level scale-up plans, which are currently being rolled out in different states in Nigeria.

    Implications for future research

    Future research could focus on time and resources saved when this system fully replaces the current spreadsheet-based system. Other research could focus on a deeper dive into data quality improvements, focusing on the aspects of availability, timeliness, and completeness.

    Reports

    Read the research summary (pdf)
    Research_Summary_HSS_Final_Reformatted_250322_RP_MI_SDS_RPRB_MIRB_ Final 11 04 22
    and
    Hints_for_Programfrom_HSS_final_v3

    Related tags

    Neglected tropical diseases (NTDs general)
    Nigeria
    Study details
    Start date
    January 2020
    Finish date
    November 2021
    Main contact
    Martins Imhansoloeva
    Research Coordinator
    mimhansoloeva@sightsavers.org
    Partners
    • Nigeria Federal Ministry of Health (FMoH)
    Countries
    Nigeria
    Themes/conditions
    Neglected tropical diseases (NTDs general)
    Study details
    Start date
    January 2020
    Finish date
    November 2021
    Main contact
    Martins Imhansoloeva
    Research Coordinator
    mimhansoloeva@sightsavers.org
    Partners
    • Nigeria Federal Ministry of Health (FMoH)
    Countries
    Nigeria
    Themes/conditions
    Neglected tropical diseases (NTDs general)

    Related research studies

    Research study

    Facility assessment for lymphatic filariasis-morbidity management and disability accessibility in Ghana

    Research study

    Rapid assessment of behavioural factors associated with delivery and uptake of care and services related to lymphatic filariasis

    Research study

    Potential mitigating role of ivermectin on the spread of chlamydia trachomatis by Musca sorbens

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.